United States v. Burgos-Montes

142 F.4th 48
CourtCourt of Appeals for the First Circuit
DecidedJune 30, 2025
Docket22-1714
StatusPublished
Cited by1 cases

This text of 142 F.4th 48 (United States v. Burgos-Montes) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Burgos-Montes, 142 F.4th 48 (1st Cir. 2025).

Opinion

United States Court of Appeals For the First Circuit

No. 22-1714

UNITED STATES,

Appellee,

v.

EDISON BURGOS-MONTES,

Defendant, Appellant.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO

[Hon. Jay A. García-Gregory, U.S. District Judge]

Before

Barron, Chief Judge, Thompson and Rikelman, Circuit Judges.

Alejandra Bird-López, Assistant Federal Public Defender, with whom Héctor L. Ramos-Vega, Interim Federal Public Defender, District of Puerto Rico, Franco L. Pérez-Redondo, Assistant Federal Public Defender, Supervisor, Appeals Section, and Rachel Brill, Federal Public Defender, District of Puerto Rico, were on brief, for appellant.

Sean P. Murphy, with whom W. Stephen Muldrow, United States Attorney, Mariana E. Bauzá-Almonte, Assistant United States Attorney, Chief, Appellate Division, and David C. Bornstein, Assistant United States Attorney, were on brief, for appellee. June 30, 2025 RIKELMAN, Circuit Judge. Edison Burgos-Montes, who is

in his mid-fifties and serving a life sentence, seeks compassionate

release based on his serious medical conditions. In late 2021,

Burgos filed a motion with the district court requesting his

release, arguing primarily that the Bureau of Prisons' (BOP)

ongoing failure to provide adequate treatment for his severe

hypertension and obstructive sleep apnea was an "extraordinary and

compelling reason[]" to reduce his sentence. 18 U.S.C. § 3582(c).

The district court found that Burgos was receiving "adequate

medical, dental and psychological care" and denied his motion

without prejudice. Burgos contends that this finding was clearly

erroneous, and we agree in part. We conclude that the district

court overlooked the undisputed evidence demonstrating that,

almost one year after Burgos's sleep apnea diagnosis and despite

his ongoing severe hypertension, the BOP had yet to provide Burgos

with the established treatment for sleep apnea. Thus, we vacate

the district court's order and remand for further proceedings

consistent with this opinion.

- 3 - I. BACKGROUND

A. Relevant Facts

Burgos began serving his prison sentence at USP Pollock,

a BOP Care Level 1 medical facility.1 During his time at Pollock,

he suffered from uncontrolled hypertension, which places an

individual at risk of congestive heart failure, heart attack, and

death. Obstructive sleep apnea can cause or exacerbate

hypertension.

Burgos's medical records from Pollock are replete with

evidence of his chronically high blood pressure. The records

include regular blood pressure readings ranging from 164/94 on the

low end to 201/117 on the high end, indicating a hypertensive

crisis. Indeed, in 2021, medical records show Burgos with only

one normal blood pressure reading.

Even though Pollock medical staff prescribed Burgos six

different antihypertensive medications, his high blood pressure

persisted. The staff's attempts to adjust the combination and

dosage of Burgos's medications did not improve his condition. On

According to the BOP's Care Level Classification Guide, Care 1

Level 1 inmates "are less than 70 years of age," "are generally healthy," and may have "limited medical needs that can be easily managed by clinician evaluations every 6-12 months." Fed. Bureau of Prisons, Clinical Guidance: Care Level Classification for Medical and Mental Health Conditions or Disabilities 2 (2019), https://www.bop.gov/resources/pdfs/care_level_classification_gui de.pdf [https://perma.cc/3P9N-UAK2] [hereinafter "BOP Clinical Guidance"].

- 4 - top of his hypertension, Burgos also reported experiencing

headaches and chest pains so severe that they caused him to vomit.

As a result, the Pollock medical staff prescribed a new medication

specifically to manage his chest pain.

Burgos's high blood pressure readings continued even

after the BOP transferred him to FCC Coleman, a Care Level 3

medical facility, in September 2021.2 For example, Burgos was

hospitalized for three days in June 2022, after multiple elevated

blood pressure readings on a single day (175/104, 193/133, and

204/129), two of which reached crisis levels. And earlier that

year, Burgos ran out of his antihypertensive medications for five

days and his blood pressure required him to reschedule a dental

procedure.

Coleman medical staff also tried to adjust Burgos's

medication regimen and took him off one medication, furosemide.

After his hospitalization, however, the medical staff

re-prescribed furosemide.

The parties point to conflicting evidence in the record

regarding whether and to what extent Burgos contributed to his

medication regimen disruptions. The government highlights

2Care Level 3 inmates "have complex, and usually chronic" conditions that require "frequent clinical contacts to maintain control or stability of their condition." They also may "require periodic hospitalization." BOP Clinical Guidance, supra note 1, at 3.

- 5 - statements in Burgos's medical records that furosemide was

discontinued "due to misuse/diversion by the inmate." But a

contemporaneous evaluation from a Coleman staff member states that

Burgos was "taking [his] medication in correct dosages at [the]

correct time" in a "responsible" manner. Relatedly, the parties

also dispute whether the five-day lapse in medication that

postponed Burgos's dental procedure was the result of him "not

taking his medications due to side effects," or the result of

medical staff negligence.

Both before and after his transfer to Coleman, Burgos

also complained of problems sleeping: He regularly woke up "gasping

for air," snored loudly during the night, and experienced fatigue

and trouble concentrating during the day. After scoring poorly on

a sleep questionnaire, he received a provisional sleep apnea

diagnosis in October 2020, while he was still at Pollock.

Burgos was scheduled for a "specialty procedure" related

to his difficulty breathing, presumably a sleep study, by the

"target date" of December 31, 2020. According to his medical

records, however, he did not undergo a sleep study at Pollock until

six months later, on June 30, 2021. Following that sleep study,

Burgos received a confirmatory diagnosis of sleep apnea in October

2021, soon after his transfer to Coleman. For unexplained reasons,

this diagnosis was not contemporaneously recorded in Burgos's

medical file.

- 6 - Even after undergoing the June 2021 sleep study and

receiving a sleep apnea diagnosis in October 2021, Burgos did not

receive the standard treatment for sleep apnea: a Continuous

Positive Airway Pressure (CPAP) machine.3 In April 2022, Burgos

met with an outside cardiologist, who recommended that Burgos

receive a CPAP machine "ASAP, as this will improve blood pressure

values and energy." Still, Burgos was not provided with a CPAP

machine.

In May 2022, nearly a year after his first sleep study,

Burgos completed another sleep questionnaire at Coleman, which

again indicated that he suffered from obstructive sleep apnea.

Coleman medical staff recommended that Burgos undergo a second

sleep study but did not indicate in his file why another study was

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
142 F.4th 48, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-burgos-montes-ca1-2025.